Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma

BMC Cancer

Table 2 Correlations between the clinicopathological factors and density of the CD23⁺ cells

Characteristics		N	CD23
Characteristics		N	High	Low	p-Value
Age	< 70	152	39	113
Age	≥ 70	84	20	64	0.753
Sex	Male	194	44	150
Sex	Female	42	15	27	0.086
History of other cancer	No	204	51	153
History of other cancer	Yes	32	8	24	1.000
Location	Ce / Ut	21	5	16
	Mt	142	34	108
	Lt / Ae	73	20	53	0.852
cT category	T 1 / 2	111	28	83
cT category	T 3 / 4	125	31	94	0.940
cN category	N -	88	22	66
cN category	N +	148	37	111	1.000
cStage category	0 - II	119	31	88
cStage category	III / IVa	117	28	89	0.707
Neoadjuvant Chemotherapy	No	84	15	69
Neoadjuvant Chemotherapy	Yes	152	44	108	0.055
Myelosuppression grade	≤ 2	131	35	96
	3	14	4	11
	4	7	5	1	0.058
pT category	T 1a / 1b / 2	137	36	101
pT category	T 3 / 4a	99	23	76	0.593
pN category	N 0	103	27	76
pN category	N 1 - 4	133	32	101	0.705
pStage category	0 - II	143	39	104
pStage category	III / IVa	93	20	73	0.314
Histological therapeutic effect	0 / 1a	114	32	82
Histological therapeutic effect	1b / 2	38	12	28	0.681
Adjuvant chemotherapy	No	135	38	97
Adjuvant chemotherapy	Yes	101	21	80	0.194

Ce Cervical esophagus, Ut Upper thoracic esophagus, Mt Middle thoracic esophagus, Lt lower thoracic esophagus, Ae Abdominal eso-phagus, T Depth of invasion, N Nodal status

ISSN: 1471-2407